B1-derived IgM or IgA autoantibodies could enter normal CNSs via transcytosis from CNS ventricles where B1 B cells reside or could enter CNSs from blood vessels during pathological conditions such as TBI, MS, AD, or epilepsy when the BBB becomes compromised. Here, CD40LG is linked to myeloid sarcoma.